The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALIBABA GROUP HLDG LTD SPONSORED ADS 01609W102   30,460,778 298,109 SH   SOLE   298,109 0 0
BILIBILI INC SPONS ADS REP Z 090040106   10,660,634 453,644 SH   SOLE   453,644 0 0
FUTU HLDGS LTD SPON ADS CL A 36118L106   4,719,128 91,015 SH   SOLE   91,015 0 0
GAOTU TECHEDU INC SPONSORED ADS 36257Y109   1,510,081 357,839 SH   SOLE   357,839 0 0
H WORLD GROUP LTD SPONSORED ADS 44332N106   2,247,447 45,885 SH   SOLE   45,885 0 0
HH&L ACQUISITION CO *W EXP 02/04/202 G39714129   28,000 400,000 SH   SOLE   400,000 0 0
TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS 874039100   3,686,848 39,635 SH   SOLE   39,635 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   116,775 750,000 SH   SOLE   750,000 0 0
YS BIOPHARMA CO LTD ORDINARY SHARES G9845F109   2,571,480 1,607,175 SH   SOLE   1,607,175 0 0